Member Info for OilMan1984

John1959 - INF B1a was the drug will being trailed as the multi therapy treatment as part of the Solidarity Trial. My conclusion to the article posted from Lancet is that its a 'typo'.

If anybody has another though then please let me know.

Cheers

Well done Wisha the potential here is fantastic. Lets see what the next few weeks brings!!

News should be due soon then this move, quickly!

Interpretation Early triple antiviral therapy was safe and superior to lopinavir–ritonavir alone in alleviating symptoms
and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19. Future
clinical study of a double antiviral therapy with interferon beta-1b as a backbone is warranted.

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)31042-4.pdf

https://twitter.com/stockman1976/status/1280844843615506437

Wisha, really surprised the SP is still at these levels considering the volume over the last few sessions!!!

Thoughts?????

My buy is sowing as sell!!!!!

Another 2133 shares getting mopped up. Lets see how it shows.................

Nothing back from yesterdays email as of yet?

Lets see if today brings any news??

6 hours old:

Remaining arms in the Solidarity trial currently include treatment with remdesivir and lopinavir/ritonavir with interferon beta-1a.

https://ajp.com.au/news/who-drops-two-trial-arms-for-covid-19-treatment/

Article 1 hour old:

https://marketresearchpublicist.com/global-digital-neuritis-drug-market-demand-growth-analysis-and-top-companies-biofer-spa-xinhua-pharm-shanghai-general-pharmaceutical-co-ltd/

Low volume on the Naz today. Lets not forget we spiked to e12.5 euros a share at one point.

Imagine the hike in price when good news lands!!!

Lots of fantastic info' posted on here over the last few days.

Well done everyone!!

Article only 2 hours old..........................

https://3wnews.org/uncategorised/2039247/interferon-beta-1a-market-growth-by-manufacturers-type-and-application-forecast-to-2026-2/

Great Spot Cwebb: https://www.medrxiv.org/content/10.1101/2020.05.28.20116467v1

https://www.pagepressjournals.org/index.php/gc/article/view/9093

A communication in the form of publications in international peer-reviewed journals will detail the results. In addition, given the adaptive nature of the Solidarity trial and its European “daughter” trial Discovery, a reflection is underway on the evolution of the protocol. In addition to the ongoing evaluation of Remdesivir and interferon, this includes the possibility of testing new treatments.

https://presse.inserm.fr/en/discovery-stopping-inclusions-in-two-treatment-groups/40087/amp/?__twitter_impression=true

https://twitter.com/kristinesabillo/status/1279670425606184960

https://www.google.co.uk/amp/s/amp.rappler.com/nation/265737-doh-stop-giving-patients-lopinavir-ritonavir-following-experts-advice

https://www.aa.com.tr/en/europe/who-criticized-for-contradictory-covid-19-statements/1902436

By the time LBE is common knowledge most investors will of missed the first sailing. I believe RRE went to £3.50 on the first acquisition? Imagine if we have the same % increase at LBE!!

HH mentioned in his interview with proactive investor that discussions were already ongoing for acquisitions. Well that was several months ago so news could be due imminently. Let’s just hope that the recent negativity with oil prices isn’t being detrimental to potential funding.

Anyway, suppose i better top up tomorrow!!!